| Date Filed | Type | Description |
| 08/23/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,309 shares
@ $22.59, valued at
$52.2k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 2,526 shares
@ $0.68, valued at
$1.7k
Sold 2,526 shares
@ $25.03, valued at
$63.2k
Exercised 2,526 options to buy
@ $0.68, valued at
$1.7k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 4,800 shares
@ $28.44, valued at
$136.5k
|
|
| 01/05/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 82,240 shares
@ $0
Sold 5,029 shares
@ $28.73, valued at
$144.5k
Granted 246,720 options to buy
@ $27.63, valued at
$6.8M
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 9,491 shares
@ $34.72, valued at
$329.5k
|
|
| 02/11/2022 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,719 shares
@ $37.5519, valued at
$102.1k
Exercised 64,631 options to buy
@ $5.28, valued at
$341.3k
Exercised 6,118 options to buy
@ $9.6, valued at
$58.7k
|
|
| 01/07/2022 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 5,007 shares
@ $44.78, valued at
$224.2k
|
|
| 01/05/2022 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 62,000 shares
@ $0
Granted 186,500 options to buy
@ $47.27, valued at
$8.8M
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,659 shares
@ $48.61, valued at
$80.6k
Sold 16,674 shares
@ $49.87, valued at
$831.5k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 06/18/2020 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Gifted 40,000 shares
@ $0 |
|
| 04/01/2020 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 4,807 shares
@ $19.48, valued at
$93.6k
|
|
| 04/01/2020 |
4/A
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 5,515 restricted stock units
@ $0
Exercised 8,800 restricted stock units
@ $0 |
|
|